| 120 |
Inhibition of 5α-reductase leading to Leydig cell tumors (in rat) |
Charles Wood |
BY-SA |
1617: Inhibition, 5α-reductase
|
745: Increase, Leydig cell tumors
|
|
|
| 119 |
Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse) |
Charles Wood |
BY-SA |
279: Thyroperoxidase, Inhibition
|
741: Increase, Adenomas/carcinomas (follicular cell)
|
|
|
| 118 |
Chronic cytotoxicity leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
BY-SA |
786: Increase, Cytotoxicity (hepatocytes)
|
719: Increase, hepatocellular adenomas and carcinomas
|
|
|
| 116 |
Cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat) |
Charles Wood |
BY-SA |
783: Increase, Cytotoxicity (tubular epithelial cells)
|
713: Increase, Adenomas/carcinomas (renal tubular)
|
|
|
| 115 |
Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat) |
Charles Wood |
BY-SA |
780: Increase, Cytotoxicity (epithelial cells)
|
779: Increase, Papillomas/carcinomas (squamous cells)
|
|
|
| 114 |
HPPD inhibition leading to corneal papillomas and carcinomas (in rat) |
Charles Wood |
BY-SA |
766: Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme
|
779: Increase, Papillomas/carcinomas (squamous cells)
|
|
|
| 113 |
Glutamate-gated chloride channel activation leading to acute mortality |
Helen Poynton |
BY-SA |
760: Activation, Glutamate-gated chloride channel
|
2 AOs
|
|
|
| 112 |
Increased dopaminergic activity leading to endometrial adenocarcinomas (in Wistar rat) |
Charles Wood |
BY-SA |
746: Increase, Dopaminergic activity
|
773: Increase, Endometrial adenocarcinomas
|
|
|
| 111 |
Decrease in androgen receptor activity leading to Leydig cell tumors (in rat) |
Charles Wood |
BY-SA |
1614: Decrease, androgen receptor activation
|
745: Increase, Leydig cell tumors
|
|
|
| 110 |
Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse) |
Charles Wood |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
741: Increase, Adenomas/carcinomas (follicular cell)
|
|
|
| 439 |
Activation of the AhR leading to metastatic breast cancer |
Louise Benoit |
BY-SA |
18: Activation, AhR
|
1982: metastatic breast cancer
|
Under Review |
1.105 |
| 440 |
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia |
Kalyan Gayen |
BY-SA |
1046: Suppression, Estrogen receptor (ER) activity
|
2 AOs
|
Under Development |
1.104 |
| 442 |
Binding to voltage gate sodium channels during development leads to cognitive impairment |
Iris Mangas |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
WPHA/WNT Endorsed |
1.91 |
| 374 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis |
Anna Price |
BY-SA |
1739: Binding to ACE2
|
1841: Encephalitis
|
Under Development |
1.96 |
| 376 |
Androgen receptor agonism leading to male-biased sex ratio |
Dan Villeneuve |
BY-SA |
25: Agonism, Androgen receptor
|
360: Decrease, Population growth rate
|
WPHA/WNT Endorsed |
1.12 |
| 381 |
Binding of viral S-glycoprotein to ACE2 receptor leading to dysgeusia |
Young Jun Kim |
BY-SA |
1739: Binding to ACE2
|
1850: dysgeusia
|
Under Development |
1.96 |
| 382 |
Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis |
Young Jun Kim |
BY-SA |
1851: Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)
|
1276: Lung fibrosis
|
Under Development |
1.96 |
| 383 |
Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis |
Young Jun Kim |
BY-SA |
1740: Induced dysregulation of ACE2
|
344: Increase, Liver fibrosis
|
Under Development |
1.96 |
| 392 |
Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation |
Penny Nymark |
BY-SA |
2 MIEs
|
1868: Hyperinflammation
|
Under Development |
1.96 |
| 394 |
SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia) |
Sandra Coecke |
BY-SA |
1739: Binding to ACE2
|
1873: impaired olfactory function (anosmia)
|
Under Development |
1.96 |
| 395 |
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke) |
Magda Sachana |
BY-SA |
1739: Binding to ACE2
|
1875: Cerebrovascular disease (stroke)
|
Under Development |
1.96 |
| 397 |
Bulky DNA adducts leading to mutations |
Carole Yauk |
BY-SA |
1879: Bulky DNA adducts, increase
|
185: Increase, Mutations
|
Under Development |
1.11 |
| 82 |
Abnormal role change in worker caste contributes to reduced brood care and leads to colony loss/failure |
Carlie LaLone |
BY-SA |
None
|
2 AOs
|
|
|
| 90 |
Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure 2 |
Carlie LaLone |
BY-SA |
559: Activation, Nicotinic acetylcholine receptor
|
2 AOs
|
|
|
| 89 |
Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure |
Carlie LaLone |
BY-SA |
559: Activation, Nicotinic acetylcholine receptor
|
563: Death/Failure, Colony
|
|
|